Isolation and identification of SARS-CoV-2 antibodies from COVID-19 patient samples

Isolation and identification of SARS-CoV-2 antibodies from COVID-19 patient samples

<p>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is the causing agent for COVID-19, has led to over 7 million deaths since it was first detected in Wuhan, China in December 2019. Antibodies induced by both vaccination and infection are crucial for the immune protection ag...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awdur:	Liu, C
Awduron Eraill:	Screaton, GR
Fformat:	Traethawd Ymchwil
Iaith:	English
Cyhoeddwyd:	2024
Pynciau:	Immunology

Eitemau Tebyg

SARS-CoV-2 infection induces robust mucosal antibody responses in the upper respiratory tract
gan: Alba Escalera, et al.
Cyhoeddwyd: (2024-03-01)

Variant-specific antibody response following repeated SARS-CoV-2 vaccination and infection
gan: Xiao-Lin Jiang, et al.
Cyhoeddwyd: (2024-07-01)

Broad sarbecovirus neutralization by combined memory B cell antibodies to ancestral SARS-CoV-2
gan: Cyril Planchais, et al.
Cyhoeddwyd: (2024-07-01)

SARS-CoV-2 neutralizing antibodies in patients with varying severity of acute COVID-19 illness
gan: Jeewandara, C, et al.
Cyhoeddwyd: (2021)

Cross-reactive immunity to SARS-CoV-2 and related coronaviruses
gan: Jay, C
Cyhoeddwyd: (2023)

Nonhuman primate antigenic cartography of SARS-CoV-2
gan: Annika Rössler, et al.
Cyhoeddwyd: (2025-01-01)

Studies on immunoreceptor activation and SARS-CoV-2 RBD/ACE2 interactions
gan: Barton, MI
Cyhoeddwyd: (2022)

Anti-SARS-CoV-2 antibodies in a nasal spray efficiently block viral transmission between ferrets
gan: Kiira Gildemann, et al.
Cyhoeddwyd: (2024-07-01)

SARS-CoV-2 produces a microRNA CoV2-miR-O8 in patients with COVID-19 infection
gan: Elise J. Tucker, et al.
Cyhoeddwyd: (2024-01-01)

Epitopes recognition of SARS-CoV-2 nucleocapsid RNA binding domain by human monoclonal antibodies
gan: Youngchang Kim, et al.
Cyhoeddwyd: (2024-02-01)

Development of human monoclonal antibodies against SARS-CoV-2
gan: Wong, Joel Xu En
Cyhoeddwyd: (2021)

SARS-CoV-2 infection elucidates features of pregnancy-specific immunity
gan: Dong Sun Oh, et al.
Cyhoeddwyd: (2024-11-01)

Multivariate analyses and machine learning link sex and age with antibody responses to SARS-CoV-2 and vaccination
gan: Miroslava Cuperlovic-Culf, et al.
Cyhoeddwyd: (2024-08-01)

Overcoming antibody-resistant SARS-CoV-2 variants with bispecific antibodies constructed using non-neutralizing antibodies
gan: Tetsuya Inoue, et al.
Cyhoeddwyd: (2024-04-01)

Increasing Sporadic Covid-19 Cases:Should We Heed Airborne Transmission Of SARS-CoV-2?
gan: Ahmad Mahfuz, Gazali
Cyhoeddwyd: (2021)

An unconventional VH1-2 antibody tolerates escape mutations and shows an antigenic hotspot on SARS-CoV-2 spike
gan: Banghui Liu, et al.
Cyhoeddwyd: (2024-06-01)

Characterisation of HBV and SARS-CoV-2 spike specific T cells and their association with viral control
gan: Liu, G
Cyhoeddwyd: (2023)

Functional diversification of innate and inflammatory immune responses mediated by antibody fragment crystallizable activities against SARS-CoV-2
gan: Martina Severa, et al.
Cyhoeddwyd: (2024-05-01)

SARS-CoV-2 vaccine development and challenges
gan: Duan Fugang, et al.
Cyhoeddwyd: (2021-03-01)

Elucidating factors of heterogeneous immune response to SARS-CoV-2 and human immunodeficiency virus
gan: Lim, N
Cyhoeddwyd: (2024)

Deciphering a reliable synergistic bispecific strategy of rescuing antibodies for SARS-CoV-2 escape variants, including BA.2.86, EG.5.1, and JN.1
gan: Zhou Tong, et al.
Cyhoeddwyd: (2024-06-01)

SARS-CoV-2 ferritin nanoparticle vaccines produce hyperimmune equine sera with broad sarbecovirus activity
gan: Elizabeth J. Martinez, et al.
Cyhoeddwyd: (2024-10-01)

Variant- and vaccination-specific alternative splicing profiles in SARS-CoV-2 infections
gan: Sung-Gwon Lee, et al.
Cyhoeddwyd: (2024-03-01)

Protein nanoparticle vaccines induce potent neutralizing antibody responses against MERS-CoV
gan: Cara W. Chao, et al.
Cyhoeddwyd: (2024-12-01)

SARS-CoV-2 antigen-carrying extracellular vesicles activate T cell responses in a human immunogenicity model
gan: Sarah E. Cummings, et al.
Cyhoeddwyd: (2024-01-01)

A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta
gan: Carter, Brandon, et al.
Cyhoeddwyd: (2023)

tANCHOR-cell-based assay for monitoring of SARS-CoV-2 neutralizing antibodies rapidly adaptive to various receptor-binding domains
gan: Daniel Ivanusic, et al.
Cyhoeddwyd: (2024-03-01)

Immunity against conserved epitopes dominates after two consecutive exposures to SARS-CoV-2 Omicron BA.1
gan: Alexander Muik, et al.
Cyhoeddwyd: (2024-08-01)

Convergence of SARS-CoV-2 spike antibody levels to a population immune setpointResearch in context
gan: Eric J. Nilles, et al.
Cyhoeddwyd: (2024-10-01)

Characterising the T cell responses to SARS-CoV-2 including variants of concern induced by natural infection and vaccines
gan: Adele, S
Cyhoeddwyd: (2024)

Differential immunometabolic responses to Delta and Omicron SARS-CoV-2 variants in golden syrian hamsters
gan: Rajesh Rajaiah, et al.
Cyhoeddwyd: (2024-08-01)

Rapid spread of the SARS-CoV-2 JN.1 lineage is associated with increased neutralization evasion
gan: Lu Zhang, et al.
Cyhoeddwyd: (2024-06-01)

Evolution of protective SARS-CoV-2-specific B and T cell responses upon vaccination and Omicron breakthrough infection
gan: Mohamed I.M. Ahmed, et al.
Cyhoeddwyd: (2024-06-01)

Immune imprinting of SARS-CoV-2 responses: changing first immune impressions
gan: J. Torresi, et al.
Cyhoeddwyd: (2024-04-01)

Safety and immunogenicity of VLPCOV-02, a SARS-CoV-2 self-amplifying RNA vaccine with a modified base, 5-methylcytosine
gan: Masayuki Aboshi, et al.
Cyhoeddwyd: (2024-02-01)

A systems biology approach to define SARS-CoV-2 correlates of protection in non-human primates
gan: Brady, C
Cyhoeddwyd: (2024)

The alarmin IL-33 exacerbates pulmonary inflammation and immune dysfunction in SARS-CoV-2 infection
gan: Hui Wang, et al.
Cyhoeddwyd: (2024-06-01)

SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway
gan: Willett, BJ, et al.
Cyhoeddwyd: (2022)

SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19
gan: Hirsch, C, et al.
Cyhoeddwyd: (2021)

SARS‐CoV‐2‐neutralising monoclonal antibodies for treatment of COVID‐19
gan: Kreuzberger, N, et al.
Cyhoeddwyd: (2021)